sevenspikes.themes.common.filters
sevenspikes.themes.common.closemenu

马来酸桂哌齐特,Cinepazide maleate;≥98% (HPLC)

别名:(E)-1- [4-(2-氧代-2-吡咯烷-1-基乙基)哌嗪-1-基] -3-(3,4,5-三甲氧基苯基)丙-2-烯-1-马来酸酯;1-(吡咯烷基-1-羰基)-甲基-4-(3,4,5-三甲氧基肉桂酰基)-哌嗪-马来酸酯;(E)-1-[4-(2-Oxo-2-pyrrolidin-1-ylethyl)piperazin-1-yl]-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one maleate, 1-(Pyrrolidinyl-1-carbonyl)-methyl-4-(3,4,5-trimethoxycinnamoyl)-piperazine-maleate

CAS号 26328-04-1 经验分子式(希尔表示法) C22H31N3O5 · C4H4O4 分子量 533.57 MDL number MFCD01320526 PubChem Substance ID 329825922
制造商品牌: 西格玛 Sigma-Aldrich
货号(SKU): SML1498
CAS号: 26328-04-1
MDL号: MFCD01320526
增值税发票 √ 免费送货 √ 订货电话:010-68689484
$262.99

产品描述

General description

Cinepazide maleate can be synthesized from ethyl chlorocarbonate activation and (E) 3,4,5-trimethoxycinnamylic acid.[1]

可以由氯碳酸乙酯活化和(E)3,4,5-三甲氧基肉桂酸合成。

包装

50 mg in glass bottle

Biochem/physiol Actions

Cinepazide maleate is a vasodilator used clinically in China used in China for the treatment of cardiovascular and cerebrovascular diseases, and peripheral vascular diseases. Cinepazide maleate is thought to act as a potentiator of adenosine A2 receptors and has also been characterized as a calcium channel blocker. It was withdrawn for agranulocytosis in several countries.

是一种在中国临床使用的血管扩张药,在中国用于治疗心脑血管疾病和周围血管疾病。 马来酸桂哌齐特被认为是腺苷A2受体的增效剂,也被认为是钙通道阻滞剂。

性质

Quality Level  100
assay  ≥98% (HPLC)
form  powder
storage condition  desiccated
color  white to beige
solubility  H2O: 20 mg/mL, clear
storage temp.  2-8°C
SMILES string  O=C(O)/C=C\C(O)=O.O=C(N1CCN(CC(N2CCCC2)=O)CC1)/C=C/C3=CC(OC)=C(OC)C(OC)=C3
InChI  1S/C22H31N3O5.C4H4O4/c1-28-18-14-17(15-19(29-2)22(18)30-3)6-7-20(26)25-12-10-23(11-13-25)16-21(27)24-8-4-5-9-24;5-3(6)1-2-4(7)8/h6-7,14-15H,4-5,8-13,16H2,1-3H3;1-2H,(H,5,6)(H,7,8)/b7-6+;2-1-
InChI key  XSTJTOKYCAJVMJ-GVTSEVKNSA-N


安全信息

符号 
GHS07  GHS07
信号词 Warning
危害声明 H302
警示性声明 P301 + P312 + P330
RIDADR NONH for all modes of transport
WGK德国 WGK 3
商品规格
属性名称属性值
储存温度 Storage temp.2-8°C冷藏
全球实时库存 Availability √美国St. Louis ≥ 33 | 欧洲Eur. ≥ 27 | 東京Tokyo ≥ 9 | 香港与北京 ≥ 16